Praser Therapeutics Raises $50 billion Pre-Seed
Praser Therapeutics has a tracked Pre-Seed round of $50 billion in Capvizr's funding dataset.
Pre-Seed$50 billionTotal tracked $50 billionUndisclosed HQ
What it does
Capvizr has a factual funding record for this company, but source material is too thin for MD-grade operating analysis.
Traction
No Limit Holdings participated in the latest tracked round; deeper traction analysis is held until source support is strong enough.
Trend impact
MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.
Funding history
- July 16, 2026 · Pre-Seed · $50 billion · No Limit Holdings